atai Life Sciences (NASDAQ:ATAI, ETR:9VC), a clinical-stage biopharmaceutical company focused on developing mental health treatments, will participate in several September investor conferences.
Management will join fireside chats at the Cantor Global Healthcare Conference on September 5 in New York, the H.C. Wainwright Twenty-Seventh Annual Global Investment Conference on September 8 in New York, and the TD Cowen Fifth Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Summit on September 17 virtually.
Webcasts will be available online.